"","X.1","X","miRNA","mRNA","PCC.cor","p_value","adjusted_p_value","score","energy","query_start_end","subject_start_end","total_bp_shared","query_similar","subject_similar","V3","Protein.names","Organism","Gene.Ontology..biological.process.","Gene.Ontology.IDs"
"20",20,6882,"Cluster_15726","Peve_00027432",-0.99995514319204,0.00602991134659825,0.573710369894872,156,-20.62,"2 21","242 264",22,"72.73%","77.27%","Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"42",44,14502,"Cluster_4629","Peve_00017735",0.997938030915672,0.0408894104551393,0.909359886114279,145,-20.33,"2 20","661 685",21,"66.67%","71.43%",NA,NA,NA,NA,NA
"66",68,27725,"Cluster_1167","Peve_00020387",0.997608159669892,0.0440400511406639,0.923878309135209,156,-20.73,"2 21","935 956",19,"68.42%","73.68%","C3YWU0","Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase)","Branchiostoma floridae (Florida lancelet) (Amphioxus)","fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]","GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139"
"74",76,30063,"Cluster_796","Peve_00020926",0.99976239721897,0.0138780829858655,0.720093853779252,161,-25.6,"2 21","197 216",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"82",84,33114,"Cluster_13502","Peve_00015952",0.997844556977271,0.0418062711782387,0.909359886114279,162,-21.27,"2 19","471 492",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"117",126,48373,"Cluster_15890","Peve_00013095",-0.99757658370632,0.0443299128918105,0.926127022176621,180,-23.84,"2 21","676 697",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"137",146,55677,"Cluster_4629","Peve_00034505",0.997938030915673,0.0408894104551382,0.909359886114279,158,-20.97,"2 20","824 846",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"170",179,67107,"Cluster_4629","Peve_00029667",0.997938030915673,0.0408894104551382,0.909359886114279,154,-20.44,"2 19","313 334",17,"70.59%","76.47%","Q9I8C7","Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10)","Gallus gallus (Chicken)","chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165]","GO:0004888; GO:0005231; GO:0005262; GO:0005886; GO:0005892; GO:0007165; GO:0007268; GO:0010996; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051899; GO:1904315"
"184",197,73083,"Cluster_796","Peve_00031940",-0.999663016871668,0.0165276609923165,0.773377054133803,155,-20.27,"2 21","182 200",19,"78.95%","78.95%","Q90WU3","ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)","Gallus gallus (Chicken)","DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]","GO:0003677; GO:0003682; GO:0003712; GO:0003724; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006397; GO:0008143; GO:0016887; GO:0032508; GO:0033677; GO:0072669"
"204",217,76890,"Cluster_9149","Peve_00008275",1,0,0,159,-24.67,"2 20","190 211",18,"66.67%","83.33%",NA,NA,NA,NA,NA
"205",218,77225,"Cluster_1167","Peve_00008279",0.999909726776791,0.00855416971793915,0.573710369894872,146,-21.82,"2 20","557 582",22,"63.64%","68.18%",NA,NA,NA,NA,NA
"219",232,82142,"Cluster_6904","Peve_00026650",-0.998173851896017,0.0384794833063837,0.909359886114279,147,-20.08,"2 21","106 132",24,"58.33%","70.83%","Q7ZVH1","Membrane progestin receptor gamma-A (mPR gamma-A) (Progestin and adipoQ receptor family member V-A)","Danio rerio (Zebrafish) (Brachydanio rerio)","oogenesis [GO:0048477]","GO:0005496; GO:0016020; GO:0038023; GO:0048477"
"246",260,96762,"Cluster_4629","Peve_00010128",0.997938030915672,0.0408894104551393,0.909359886114279,142,-20.17,"2 20","86 111",22,"59.09%","68.18%",NA,NA,NA,NA,NA
"251",265,98974,"Cluster_6906","Peve_00029665",-0.997478929018431,0.0452146257420912,0.931728931996319,159,-21.73,"2 21","933 956",21,"71.43%","76.19%",NA,NA,NA,NA,NA
"274",289,104070,"Cluster_9149","Peve_00034585",1,9.48637384723993e-09,6.86838308108347e-06,147,-22.51,"2 12","409 430",10,"80.00%","100.00%",NA,NA,NA,NA,NA
"303",318,113861,"Cluster_4115","Peve_00008964",-0.999794894490907,0.0128941051315395,0.697679744941,171,-22.26,"2 20","61 82",18,"77.78%","88.89%","Q6P9Z4","Protein fem-1 homolog A (FEM1a) (FEM1-alpha)","Danio rerio (Zebrafish) (Brachydanio rerio)","negative regulation of inflammatory response [GO:0050728]; positive regulation of inflammatory response [GO:0050729]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0000151; GO:0005739; GO:0006511; GO:0016567; GO:0031462; GO:0050728; GO:0050729; GO:0051438; GO:0140627; GO:1990756"
"311",326,116692,"Cluster_2854","Peve_00023739",0.999976082283725,0.004403072548434,0.54328949385489,157,-22.98,"2 20","334 359",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"357",374,129732,"Cluster_15726","Peve_00020651",-0.998224476405987,0.0379422100483605,0.909359886114279,149,-26.8,"2 21","742 771",27,"66.67%","70.37%","Q6ZPR4","Potassium channel subfamily T member 1","Mus musculus (Mouse)","potassium ion transport [GO:0006813]","GO:0005228; GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0016020"
"365",382,131180,"Cluster_1167","Peve_00027965",0.999909726776791,0.00855416971793389,0.573710369894872,147,-23.67,"2 18","436 460",19,"68.42%","78.95%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"371",388,134740,"Cluster_4080","Peve_00002333",-0.99984182162055,0.0113233363162533,0.656276085828034,159,-25.73,"2 21","460 487",25,"64.00%","76.00%","Q6DIV6","Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836]","GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800"
"388",407,143130,"Cluster_9149","Peve_00032772",1,9.48637384723993e-09,6.86838308108347e-06,141,-20.73,"2 14","548 569",12,"66.67%","83.33%",NA,NA,NA,NA,NA
"391",410,143952,"Cluster_15726","Peve_00027699",-0.99781061214271,0.0421342959844262,0.911075865480802,168,-24.61,"2 21","27 48",19,"78.95%","78.95%",NA,NA,NA,NA,NA
"457",483,174605,"Cluster_1167","Peve_00023767",0.999909726776791,0.00855416971793389,0.573710369894872,158,-20.46,"2 21","87 107",19,"73.68%","78.95%","Q566X8","Diencephalon/mesencephalon homeobox protein 1-B","Danio rerio (Zebrafish) (Brachydanio rerio)","midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074"
"468",495,178686,"Cluster_11134","Peve_00030028",-0.999412779421733,0.0218181040468405,0.829411399113453,170,-26.78,"2 20","224 247",20,"75.00%","90.00%",NA,NA,NA,NA,NA
"478",505,180718,"Cluster_15890","Peve_00015742",-0.998127395584257,0.0389660099841794,0.909359886114279,157,-20.18,"2 21","849 868",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"486",514,183430,"Cluster_4080","Peve_00017580",-0.999998957645573,0.000919184867929113,0.240277133272295,167,-21.45,"2 20","777 798",18,"77.78%","83.33%","Q864U6","UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (Beta-1,3-GalNAc-T1) (EC 2.4.1.79) (Beta-1,3-galactosyltransferase 3) (Beta-1,3-GalTase 3) (Beta3Gal-T3) (Beta3GalT3) (b3Gal-T3) (Beta-3-Gx-T3) (Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase) (Globoside synthase) (UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase)","Sus scrofa (Pig)","lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0008194; GO:0008499; GO:0009312; GO:0016757; GO:0047273"
"509",542,194790,"Cluster_9149","Peve_00037587",-0.997642761939907,0.0437202051657,0.921378164792108,140,-21.11,"2 9","365 386",7,"100.00%","100.00%","Q29496","Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24)","Ovis aries (Sheep)","","GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330"
"542",578,207546,"Cluster_2787","Peve_00040680",0.999851452010528,0.0109732149417988,0.647820986329688,170,-24.52,"2 21","126 149",21,"80.95%","85.71%","Q9HAT8","E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2)","Homo sapiens (Human)","positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592]","GO:0000209; GO:0001934; GO:0005829; GO:0008592; GO:0034450; GO:0043123; GO:0043410; GO:0061630"
"574",614,217355,"Cluster_1167","Peve_00043419",0.999909726776791,0.00855416971793389,0.573710369894872,158,-20.65,"2 20","290 312",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"577",617,219011,"Cluster_14999","Peve_00024854",-0.999571546587002,0.0186364175217764,0.782669382293497,163,-20.02,"2 21","853 876",21,"71.43%","80.95%","Q75ZP8","Pyranose 2-oxidase (P2Ox) (POD) (POx) (PROD) (Pyranose oxidase) (EC 1.1.3.10) (FAD-oxidoreductase) (Glucose 2-oxidase) (Pyranose:oxygen 2-oxidoreductase)","Lyophyllum shimeji (Hon-shimeji) (Tricholoma shimeji)","","GO:0050233; GO:0050660"
"642",686,241292,"Cluster_589","Peve_00035783",-0.997488611107799,0.0451276831430894,0.931124593466766,163,-30.37,"2 21","547 571",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"661",708,245130,"Cluster_5882","Peve_00018121",-0.998399871033844,0.0360189079935825,0.909359886114279,165,-20.08,"2 19","46 68",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"670",717,247755,"Cluster_9149","Peve_00006544",0.999971585054582,0.00479920788265011,0.551398425649056,145,-20.18,"2 10","1 16",8,"100.00%","100.00%","Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"687",735,251715,"Cluster_9149","Peve_00022361",-0.999345600152943,0.0230324640380137,0.844680676561554,160,-24.22,"2 13","11 32",11,"100.00%","100.00%","P98160","Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","Homo sapiens (Human)","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]","GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907"
"695",745,254636,"Cluster_8884","Peve_00013542",-0.998136715854457,0.0388688885892676,0.909359886114279,161,-21.36,"2 19","214 238",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"712",762,259292,"Cluster_589","Peve_00034862",-0.996949252337422,0.0497403384974724,0.952281411175107,155,-23.55,"2 12","279 300",10,"100.00%","100.00%","Q96CG8","Collagen triple helix repeat-containing protein 1","Homo sapiens (Human)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177"
"721",771,262985,"Cluster_1167","Peve_00004995",0.999909726776791,0.00855416971793389,0.573710369894872,142,-20.57,"2 11","93 114",9,"88.89%","88.89%",NA,NA,NA,NA,NA
"724",774,264339,"Cluster_4079","Peve_00015748",-0.999044377811527,0.0278338206502373,0.899469696283718,149,-22.68,"2 20","227 252",22,"68.18%","72.73%","P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"747",799,275360,"Cluster_1167","Peve_00041754",0.999909726776791,0.00855416971793389,0.573710369894872,142,-20.26,"2 11","782 803",9,"88.89%","88.89%",NA,NA,NA,NA,NA
"753",805,276672,"Cluster_4629","Peve_00014587",0.997938030915673,0.0408894104551382,0.909359886114279,160,-22.43,"2 21","545 566",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"758",810,278224,"Cluster_10934","Peve_00042220",0.998758250045999,0.0317290557481559,0.903929377050813,155,-22.16,"2 21","131 158",25,"64.00%","72.00%",NA,NA,NA,NA,NA
"762",814,279455,"Cluster_1167","Peve_00031993",0.999909726776791,0.00855416971793915,0.573710369894872,148,-22.03,"2 20","269 290",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"785",841,287330,"Cluster_1167","Peve_00024388",0.999909726776791,0.00855416971793389,0.573710369894872,151,-23.33,"2 12","579 600",10,"90.00%","100.00%",NA,NA,NA,NA,NA
"810",869,299350,"Cluster_4080","Peve_00031324",0.999992290678624,0.00249978970397961,0.417409525382424,171,-20.17,"2 20","9 30",18,"77.78%","88.89%","Q9CQW0","ER membrane protein complex subunit 6 (Transmembrane protein 93)","Mus musculus (Mouse)","autophagosome assembly [GO:0000045]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]","GO:0000045; GO:0005789; GO:0016020; GO:0032977; GO:0045050; GO:0071816; GO:0072546; GO:1903349"
"817",877,301536,"Cluster_11134","Peve_00035315",0.997089150362585,0.0485859177132707,0.947668828184205,163,-24.46,"2 21","718 740",20,"75.00%","80.00%","Q9VW71","Fat-like cadherin-related tumor suppressor homolog (Protein kugelei)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; centripetally migrating follicle cell migration [GO:0060269]; defense response to Gram-negative bacterium [GO:0050829]; establishment of planar polarity of follicular epithelium [GO:0042247]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; foregut morphogenesis [GO:0007440]; growth of a germarium-derived egg chamber [GO:0007295]; hindgut morphogenesis [GO:0007442]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of innate immune response [GO:0045089]; protein localization to cell leading edge [GO:1902463]; salivary gland development [GO:0007431]","GO:0005509; GO:0005886; GO:0005925; GO:0007156; GO:0007295; GO:0007424; GO:0007431; GO:0007440; GO:0007442; GO:0009925; GO:0016339; GO:0030950; GO:0031254; GO:0042247; GO:0044331; GO:0044877; GO:0045089; GO:0048477; GO:0050829; GO:0050839; GO:0051491; GO:0060269; GO:0098609; GO:0098858; GO:1902463"
"834",894,309296,"Cluster_4115","Peve_00043301",-0.999473741771815,0.0206544492090428,0.814021076298899,169,-22.8,"2 19","351 374",19,"78.95%","89.47%","Q8N3X1","Formin-binding protein 4 (Formin-binding protein 30)","Homo sapiens (Human)","","GO:0016607"
"858",919,318519,"Cluster_4079","Peve_00030841",-0.997945022574284,0.0408200045387614,0.909359886114279,160,-22.37,"2 13","341 362",11,"100.00%","100.00%","A0A481NSZ4",NA,NA,NA,NA
"861",922,320510,"Cluster_6914","Peve_00006285",0.999973885825882,0.00460080910062486,0.545608313504719,158,-20.29,"2 20","107 128",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"870",931,325234,"Cluster_6906","Peve_00011900",0.999023739066517,0.0281328295255526,0.902005420309698,157,-22.41,"2 18","850 871",16,"75.00%","81.25%",NA,NA,NA,NA,NA
"904",972,339627,"Cluster_4629","Peve_00021553",0.997938030915672,0.0408894104551393,0.909359886114279,150,-20.07,"2 20","95 120",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"909",977,341743,"Cluster_4735","Peve_00013205",-0.999762368280092,0.013878928135551,0.720093853779252,158,-24.01,"2 21","196 221",23,"73.91%","73.91%",NA,NA,NA,NA,NA
"926",999,355185,"Cluster_16738","Peve_00032724",0.999974190676381,0.00457387578916138,0.54328949385489,169,-21.23,"2 18","554 575",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"935",1008,358953,"Cluster_10061","Peve_00031409",0.999873400436456,0.0101301483856458,0.62545365403098,161,-20.62,"2 18","964 985",16,"75.00%","87.50%",NA,NA,NA,NA,NA
"954",1028,366321,"Cluster_7053","Peve_00013596",0.999599711713374,0.0180134147972475,0.782669382293497,155,-20.38,"2 20","415 434",18,"72.22%","88.89%","Q9JI70","Molecular chaperone MKKS (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) (Protein Bbs6 homolog)","Mus musculus (Mouse)","artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to leptin [GO:0044321]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311]","GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007608; GO:0010467; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0032502; GO:0033210; GO:0034260; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0044321; GO:0045444; GO:0045494; GO:0045776; GO:0046907; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902636; GO:1905515"
"984",1059,379805,"Cluster_1167","Peve_00043468",0.999909726776791,0.00855416971793915,0.573710369894872,155,-21.49,"2 21","742 764",20,"70.00%","75.00%","Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"1063",1147,415245,"Cluster_9149","Peve_00008133",-0.999965637301935,0.00527764279292991,0.551398425649056,164,-20.98,"2 20","190 209",18,"83.33%","83.33%","P58027","Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A)","Canis lupus familiaris (Dog) (Canis familiaris)","catecholamine metabolic process [GO:0006584]; neurotransmitter catabolic process [GO:0042135]","GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0042135; GO:0050660; GO:0052595; GO:0052596; GO:0097621"
"1083",1172,423595,"Cluster_4080","Peve_00001878",-0.997498841901557,0.045035631247519,0.930829896493262,169,-21.99,"2 20","37 57",18,"83.33%","88.89%",NA,NA,NA,NA,NA
"1121",1211,436980,"Cluster_9149","Peve_00036519",-0.999042227116386,0.0278651290317038,0.899642249848007,145,-20.73,"2 16","885 905",14,"71.43%","85.71%","O00468","Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Homo sapiens (Human)","animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]","GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0009887; GO:0009888; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062"
"1135",1225,442932,"Cluster_15726","Peve_00030612",1,1.34157585525081e-08,8.89340150118664e-06,159,-23.05,"2 21","67 89",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"1139",1230,445219,"Cluster_10934","Peve_00037399",0.998758250045998,0.0317290557481601,0.903929377050813,171,-22.4,"2 20","479 500",18,"83.33%","83.33%","Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"1195",1291,469717,"Cluster_2854","Peve_00038107",-0.997755955103144,0.042657179825614,0.914411088077857,148,-20.08,"2 15","945 965",13,"84.62%","84.62%",NA,NA,NA,NA,NA
"1206",1302,472110,"Cluster_5882","Peve_00034300",-0.999810125119312,0.0124061134927224,0.685998477593919,160,-22.36,"2 17","412 433",15,"73.33%","93.33%","O75976","Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180)","Homo sapiens (Human)","peptide metabolic process [GO:0006518]; protein processing [GO:0016485]","GO:0004181; GO:0004185; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0016020; GO:0016485; GO:0070062"
"1213",1311,475702,"Cluster_2854","Peve_00019126",-0.997565388064538,0.0444322335382886,0.926725506280974,174,-25.76,"2 21","237 260",21,"80.95%","90.48%",NA,NA,NA,NA,NA
"1222",1322,479380,"Cluster_14500","Peve_00006413",-0.999945819357893,0.0066270333402645,0.573710369894872,162,-21.66,"2 21","758 783",23,"73.91%","78.26%","Q9Y2I7","1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1)","Homo sapiens (Human)","1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]","GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785"
"1240",1340,487490,"Cluster_1167","Peve_00013947",0.999909726776791,0.00855416971793389,0.573710369894872,141,-21.45,"2 12","681 701",10,"90.00%","90.00%",NA,NA,NA,NA,NA
"1241",1341,488010,"Cluster_9149","Peve_00043123",1,0,0,157,-23.58,"2 21","803 824",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"1246",1346,489169,"Cluster_6906","Peve_00030693",0.999488224375111,0.0203682371525405,0.810097073649321,155,-20.73,"2 21","558 576",19,"73.68%","84.21%","Q86VD9","GPI mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3)","Homo sapiens (Human)","GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]","GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016254"
"1262",1362,494769,"Cluster_13502","Peve_00000601",0.997844556977271,0.0418062711782387,0.909359886114279,153,-21.15,"2 19","925 950",21,"66.67%","76.19%",NA,NA,NA,NA,NA
"1284",1385,502977,"Cluster_4629","Peve_00012638",0.997938030915672,0.0408894104551393,0.909359886114279,162,-20.05,"2 20","206 228",19,"73.68%","84.21%","Q92626","Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment]","Homo sapiens (Human)","angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]","GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825"
"1289",1390,504356,"Cluster_14999","Peve_00003000",-0.998266557633023,0.0374897530420475,0.909359886114279,161,-21.13,"2 14","905 926",12,"91.67%","100.00%",NA,NA,NA,NA,NA
"1363",1468,534112,"Cluster_2854","Peve_00021216",0.999962448044095,0.00551712420276166,0.551398425649056,156,-20.4,"2 20","190 209",18,"72.22%","83.33%",NA,NA,NA,NA,NA
"1372",1477,537845,"Cluster_1167","Peve_00015043",0.999909726776791,0.00855416971793915,0.573710369894872,155,-29.94,"2 21","395 419",22,"68.18%","72.73%",NA,NA,NA,NA,NA
"1373",1478,538327,"Cluster_11135","Peve_00002637",0.999511573163594,0.019898143482347,0.802868112010331,168,-21.37,"2 21","948 969",19,"68.42%","89.47%","Q8K2J9","BTB/POZ domain-containing protein 6","Mus musculus (Mouse)","neurogenesis [GO:0022008]","GO:0005829; GO:0022008"
"1379",1484,541173,"Cluster_796","Peve_00001935",0.998840928019511,0.030654361989868,0.903929377050813,159,-24.54,"2 21","302 328",24,"70.83%","70.83%","O08726","Galanin receptor type 2 (GAL2-R) (GALR-2)","Rattus norvegicus (Rat)","adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; galanin-activated signaling pathway [GO:0090663]; inositol phosphate metabolic process [GO:0043647]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0004966; GO:0005886; GO:0005929; GO:0007186; GO:0007188; GO:0007189; GO:0007194; GO:0007200; GO:0007204; GO:0007218; GO:0008528; GO:0017046; GO:0031175; GO:0042923; GO:0043647; GO:0045944; GO:0046488; GO:0090663; GO:1902608"
"1392",1497,546437,"Cluster_589","Peve_00044964",-0.999852293886836,0.0109420753621189,0.647820986329688,160,-23.7,"2 17","733 754",15,"80.00%","86.67%",NA,NA,NA,NA,NA
"1393",1498,546808,"Cluster_4735","Peve_00036516",0.999722156026375,0.0150074072356261,0.742836432891574,155,-20.6,"2 16","301 322",14,"78.57%","85.71%",NA,NA,NA,NA,NA
"1407",1512,554232,"Cluster_4629","Peve_00011858",-0.999998482798634,0.00110896231522268,0.278265881456726,162,-22.01,"2 21","146 170",22,"77.27%","77.27%","O43147","Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547]","GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630"
"1408",1513,554232,"Cluster_4629","Peve_00011858",-0.999998482798634,0.00110896231522268,0.278265881456726,162,-22.01,"2 21","586 610",22,"77.27%","77.27%","O43147","Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1)","Homo sapiens (Human)","activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547]","GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630"
"1423",1529,560930,"Cluster_1167","Peve_00029393",0.999909726776791,0.00855416971793389,0.573710369894872,149,-22.43,"2 20","154 174",18,"72.22%","72.22%","P34992","Neuropeptide Y receptor type 1 (NPY1-R)","Xenopus laevis (African clawed frog)","","GO:0004983; GO:0005886"
"1432",1539,566136,"Cluster_11134","Peve_00019237",0.99895412821558,0.0291187147996283,0.903929377050813,157,-25.17,"2 21","142 163",20,"70.00%","85.00%","P56407","Homeobox protein ceh-9","Caenorhabditis elegans","cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030154"
"1449",1557,571281,"Cluster_2787","Peve_00039724",-0.999918519895221,0.0081268802250093,0.573710369894872,161,-22.45,"2 19","175 197",18,"72.22%","88.89%","Q9Z2L6","Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase)","Mus musculus (Mouse)","","GO:0003993; GO:0005788; GO:0005886; GO:0030351; GO:0030352; GO:0034417; GO:0052745; GO:0052826"
"1459",1567,575112,"Cluster_4629","Peve_00022350",0.997938030915673,0.0408894104551382,0.909359886114279,160,-21.85,"2 21","166 187",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"1497",1605,589502,"Cluster_589","Peve_00001193",-0.99919278413099,0.0255810981953082,0.875092164569788,154,-23.1,"2 20","676 698",19,"68.42%","78.95%","P22127","Ras-related protein Rab-10 (ORA1)","Diplobatis ommata (Ocellated electric ray) (Discopyge ommata)","axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192]","GO:0003924; GO:0005525; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005929; GO:0006893; GO:0007409; GO:0016192; GO:0016197; GO:0019003; GO:0030670; GO:0030859; GO:0032593; GO:0032869; GO:0043001; GO:0045200; GO:0055037; GO:0055038; GO:0071782; GO:0071786; GO:0072659; GO:0097051; GO:1903361"
"1502",1610,591033,"Cluster_796","Peve_00012907",-0.999864535075281,0.0104788458953449,0.635656620419967,156,-20.81,"2 21","643 664",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"1519",1629,598374,"Cluster_4079","Peve_00037614",-0.997292545957876,0.0468569161220451,0.939542385262084,169,-28.14,"2 21","495 517",21,"80.95%","85.71%","P41250","Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1)","Homo sapiens (Human)","diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150"
"1545",1665,611805,"Cluster_9149","Peve_00018844",-0.998768459381639,0.031598325746414,0.903929377050813,148,-22.4,"2 17","795 813",15,"80.00%","80.00%","Q9UA35","Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (hfCNT)","Eptatretus stoutii (Pacific hagfish)","","GO:0005337; GO:0005886; GO:0015293"
"1553",1675,615207,"Cluster_4629","Peve_00000256",0.997938030915672,0.0408894104551393,0.909359886114279,150,-20.58,"2 19","641 662",17,"70.59%","70.59%",NA,NA,NA,NA,NA
"1566",1690,620187,"Cluster_15726","Peve_00007613",0.999883443510219,0.00972002918842882,0.612877211000455,157,-20.89,"2 15","292 315",15,"86.67%","86.67%","P28175","Clotting factor C (FC) (EC 3.4.21.84) (Limulus factor C) [Cleaved into: Clotting factor C heavy chain; Clotting factor C light chain; Clotting factor C chain A; Clotting factor C chain B]","Tachypleus tridentatus (Japanese horseshoe crab)","cell adhesion [GO:0007155]; hemolymph coagulation [GO:0042381]; protein processing [GO:0016485]","GO:0004252; GO:0005576; GO:0007155; GO:0016485; GO:0030246; GO:0042381"
"1572",1697,622882,"Cluster_11135","Peve_00022342",0.999706721854346,0.0154186228806241,0.751144232060475,153,-21.16,"2 21","882 905",22,"68.18%","77.27%",NA,NA,NA,NA,NA
"1624",1753,644417,"Cluster_6904","Peve_00014436",-0.999185657644639,0.0256937863850763,0.876505990190277,167,-27.12,"2 21","703 725",20,"75.00%","85.00%",NA,NA,NA,NA,NA
"1651",1786,655743,"Cluster_796","Peve_00023049",0.9999733342158,0.00464914686852433,0.548889669521695,151,-21.71,"2 21","271 297",24,"62.50%","70.83%","P54357","Myosin-2 essential light chain (Myosin II essential light chain) (Non-muscle myosin essential light chain)","Drosophila melanogaster (Fruit fly)","actin filament-based movement [GO:0030048]","GO:0005509; GO:0005829; GO:0016460; GO:0017022; GO:0030048; GO:0031475; GO:0031476; GO:0031477; GO:0032036"
"1664",1800,662150,"Cluster_6914","Peve_00012607",0.997809832643678,0.0421417987017475,0.911075865480802,166,-23.44,"2 20","358 379",19,"78.95%","84.21%","Q8CG08","Collagen triple helix repeat-containing protein 1","Rattus norvegicus (Rat)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"1687",1825,669831,"Cluster_2787","Peve_00006347",0.997397732644906,0.0459372826693576,0.934604794067411,163,-22.73,"2 21","273 297",22,"72.73%","77.27%","Q86WI1","Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1)","Homo sapiens (Human)","immune response [GO:0006955]; sensory perception of sound [GO:0007605]","GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0120234"
"1700",1838,677286,"Cluster_11134","Peve_00043325",0.999679946581222,0.0161071216942691,0.766206870688277,154,-20.57,"2 21","535 555",19,"63.16%","84.21%","Q7TPS5","C2 domain-containing protein 5 (138 kDa C2 domain-containing phosphoprotein)","Mus musculus (Mouse)","cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; vesicle fusion [GO:0006906]","GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0006906; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0046326; GO:0065002; GO:0072659; GO:0090314"
"1748",1890,693975,"Cluster_9149","Peve_00021224",1,0,0,144,-21.08,"2 18","333 357",19,"68.42%","68.42%",NA,NA,NA,NA,NA
"1779",1921,706483,"Cluster_8888","Peve_00025328",0.999964597582385,0.00535689165213977,0.551398425649056,154,-22.08,"2 20","922 939",18,"77.78%","83.33%","Q6GL87","Growth hormone-regulated TBC protein 1","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","","GO:0005096"
"1794",1936,708780,"Cluster_9149","Peve_00026910",1,0,0,165,-22,"2 19","663 685",18,"83.33%","83.33%",NA,NA,NA,NA,NA
"1838",1982,725007,"Cluster_4629","Peve_00025489",0.997938030915672,0.0408894104551393,0.909359886114279,143,-20.34,"2 12","908 929",10,"80.00%","90.00%",NA,NA,NA,NA,NA
"1842",1986,727511,"Cluster_14999","Peve_00021676",0.999075146741859,0.0273819903750951,0.894692732264905,167,-25.85,"2 16","820 841",14,"85.71%","100.00%",NA,NA,NA,NA,NA
"1856",2001,731640,"Cluster_9149","Peve_00012722",1,0,0,152,-25.13,"2 15","768 788",13,"84.62%","92.31%",NA,NA,NA,NA,NA
"1868",2014,735503,"Cluster_7658","Peve_00014491",-0.999687209109476,0.0159233151265928,0.762215157405503,167,-22.5,"2 21","16 38",20,"75.00%","85.00%","Q8L7S6","Beta-hexosaminidase 3 (EC 3.2.1.52) (Beta-GlcNAcase 3) (Beta-N-acetylhexosaminidase 3) (Beta-hexosaminidase 1) (AtHEX1) (N-acetyl-beta-glucosaminidase 3)","Arabidopsis thaliana (Mouse-ear cress)","carbohydrate metabolic process [GO:0005975]; glycosaminoglycan metabolic process [GO:0030203]","GO:0004563; GO:0005634; GO:0005886; GO:0005975; GO:0015929; GO:0016020; GO:0030203; GO:0102148"
"1904",2054,748619,"Cluster_16498","Peve_00011733",0.99999477106698,0.00205874164373314,0.362847063101065,169,-20.57,"2 21","10 31",20,"80.00%","90.00%","Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"1920",2070,753825,"Cluster_9149","Peve_00004871",1,0,0,147,-21.53,"2 12","622 643",10,"80.00%","100.00%",NA,NA,NA,NA,NA
"1939",2089,758387,"Cluster_589","Peve_00028810",-0.999776252592975,0.0134673523968407,0.710997774681485,155,-22.76,"2 12","405 426",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"1964",2116,769452,"Cluster_15726","Peve_00014069",1,9.48637384723993e-09,6.86838308108347e-06,154,-23.14,"2 20","861 888",24,"66.67%","70.83%",NA,NA,NA,NA,NA
"1974",2127,774075,"Cluster_9149","Peve_00002661",-0.998403640393818,0.0359764475202205,0.909359886114279,149,-25.07,"2 18","337 356",16,"75.00%","87.50%","E7FAM5","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Danio rerio (Zebrafish) (Brachydanio rerio)","embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0010172; GO:0010586; GO:0017148; GO:0021915; GO:0030371; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061630; GO:0072089; GO:2000177"
"2003",2156,785257,"Cluster_2854","Peve_00013531",-0.999994747981342,0.00206328129499564,0.363213043883873,176,-25.43,"2 21","596 617",19,"84.21%","84.21%","O00116","Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)","Homo sapiens (Human)","ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610]","GO:0005730; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0071949"
"2019",2172,790236,"Cluster_11134","Peve_00000891",-0.999479069517375,0.0205496231198021,0.812495585628734,156,-25.76,"2 21","699 718",19,"73.68%","84.21%","Q3KR37","Protein Aster-B (GRAM domain-containing protein 1B)","Homo sapiens (Human)","cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]; intracellular sterol transport [GO:0032366]","GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0032366; GO:0032934; GO:0042632; GO:0070300; GO:0071397; GO:0120015; GO:0120020; GO:0140268"
"2024",2178,791969,"Cluster_5563","Peve_00029721",0.999970783906393,0.00486639381889994,0.551398425649056,168,-22.23,"2 21","925 945",19,"84.21%","89.47%",NA,NA,NA,NA,NA
"2026",2180,792313,"Cluster_15890","Peve_00032829",-0.999967287119389,0.00514938897746555,0.551398425649056,162,-22.12,"2 21","284 304",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2061",2221,807747,"Cluster_15726","Peve_00043724",-0.998403640393818,0.0359764475202192,0.909359886114279,165,-27.25,"2 20","949 973",21,"80.95%","80.95%","Q9MYM7","Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)","Pongo pygmaeus (Bornean orangutan)","lipid metabolic process [GO:0006629]; protein glycosylation [GO:0006486]","GO:0000139; GO:0006486; GO:0006629; GO:0047275"
"2085",2248,816881,"Cluster_14999","Peve_00025970",-0.999571546587002,0.0186364175217764,0.782669382293497,178,-27.37,"2 20","596 618",19,"84.21%","94.74%",NA,NA,NA,NA,NA
"2088",2252,818640,"Cluster_16738","Peve_00025028",-0.9981690675047,0.0385298725994388,0.909359886114279,176,-25.72,"2 21","741 762",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"2092",2258,820355,"Cluster_1167","Peve_00043521",0.999909606796706,0.00855985249202504,0.574004478614831,146,-23.91,"2 21","190 214",22,"63.64%","72.73%",NA,NA,NA,NA,NA
"2100",2267,823755,"Cluster_9149","Peve_00039320",-0.99707405830425,0.048711769379337,0.94828359635183,153,-25.57,"2 14","871 892",12,"75.00%","100.00%",NA,NA,NA,NA,NA
"2111",2279,829812,"Cluster_4629","Peve_00000786",0.997938030915673,0.0408894104551371,0.909359886114279,162,-24.67,"2 21","469 493",22,"72.73%","81.82%",NA,NA,NA,NA,NA
"2150",2318,845624,"Cluster_8988","Peve_00040282",-0.999041633391172,0.0278737658962114,0.899642249848007,162,-21.05,"2 21","329 354",23,"69.57%","82.61%",NA,NA,NA,NA,NA
"2175",2344,861168,"Cluster_796","Peve_00033364",0.999260034938896,0.0244921839031936,0.862029780817471,145,-20.01,"2 10","259 280",8,"100.00%","100.00%","P22045","9,11-endoperoxide prostaglandin H2 reductase (EC 1.1.1.-) (Prostaglandin F2-alpha synthase)","Leishmania major","prostaglandin biosynthetic process [GO:0001516]","GO:0000166; GO:0001516; GO:0005737; GO:0036130"
"2177",2346,862066,"Cluster_29","Peve_00022058",-0.997453781157211,0.0454396710191659,0.933005102504876,162,-20.17,"2 19","370 391",17,"70.59%","88.24%",NA,NA,NA,NA,NA
"2194",2363,866910,"Cluster_9149","Peve_00024049",0.999779696086058,0.0133633148443657,0.708804190981816,168,-24.07,"2 21","603 624",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2198",2367,869097,"Cluster_4629","Peve_00007535",0.997938030915672,0.0408894104551393,0.909359886114279,159,-21.98,"2 21","431 453",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"2208",2377,873214,"Cluster_10934","Peve_00044580",0.998038064060883,0.0398849050546989,0.909359886114279,161,-21.63,"2 20","74 94",18,"77.78%","83.33%","A2RV01","Diphthine--ammonia ligase (EC 6.3.1.14) (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)","Danio rerio (Zebrafish) (Brachydanio rerio)","peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]","GO:0005524; GO:0017178; GO:0017183"
"2209",2378,873261,"Cluster_11134","Peve_00044581",0.999774208746349,0.0135287244184117,0.712341789037769,162,-21.68,"2 20","878 900",19,"78.95%","78.95%","Q28DS0","SUMO-activating enzyme subunit 1 (Ubiquitin-like 1-activating enzyme E1A)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","definitive hemopoiesis [GO:0060216]; hematopoietic stem cell homeostasis [GO:0061484]; protein sumoylation [GO:0016925]","GO:0008022; GO:0008641; GO:0016925; GO:0031510; GO:0060216; GO:0061484"
"2212",2381,874560,"Cluster_9149","Peve_00021049",-0.999226469305183,0.0250415897127703,0.869034288843014,162,-20.26,"2 19","468 489",17,"76.47%","82.35%",NA,NA,NA,NA,NA
"2222",2392,878830,"Cluster_8634","Peve_00036804",0.999713854690073,0.0152299610722912,0.747042277261995,165,-22.16,"2 18","575 596",16,"81.25%","87.50%",NA,NA,NA,NA,NA
"2241",2413,886010,"Cluster_1167","Peve_00023227",0.999689275367834,0.0158706315126451,0.761370369638947,145,-20.39,"2 10","656 677",8,"100.00%","100.00%","O54988","STE20-like serine/threonine-protein kinase (STE20-like kinase) (mSLK) (EC 2.7.11.1) (Etk4) (STE20-related kinase SMAK) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular response to type II interferon [GO:0071346]; cytoplasmic microtubule organization [GO:0031122]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]","GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0030334; GO:0031122; GO:0031252; GO:0035173; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0046777; GO:0048471; GO:0051893; GO:0071346; GO:0106310"
"2247",2419,887316,"Cluster_2787","Peve_00020556",0.997105325686941,0.0484506705316052,0.946735628940312,168,-25.54,"2 21","856 877",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2250",2422,887992,"Cluster_2854","Peve_00001444",0.999962776498024,0.00549294287464855,0.551398425649056,158,-21.78,"2 21","203 228",23,"69.57%","78.26%","Q0ZZJ6","A.superbus venom factor 1 (AVF-1) (CVF-like) (Complement C3 homolog) [Cleaved into: AVF-1 alpha chain; AVF-1 gamma chain; AVF-1 beta chain]","Austrelaps superbus (Lowland copperhead snake) (Hoplocephalus superbus)","complement activation [GO:0006956]; inflammatory response [GO:0006954]","GO:0004866; GO:0005615; GO:0006954; GO:0006956; GO:0046872; GO:0090729"
"2262",2434,889527,"Cluster_4629","Peve_00013823",-0.996949447613843,0.0497387457379489,0.952281411175107,154,-20.35,"2 15","722 743",13,"84.62%","84.62%","A0A2J6RX17",NA,NA,NA,NA
"2312",2490,909731,"Cluster_4115","Peve_00040371",-0.998463578089383,0.0352944149574942,0.909359886114279,166,-23.07,"2 19","609 630",17,"70.59%","94.12%","P35658","Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN)","Homo sapiens (Human)","mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405]","GO:0000278; GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876"
"2315",2493,909795,"Cluster_9149","Peve_00040370",1,0,0,161,-25.16,"2 19","356 380",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"2319",2498,911826,"Cluster_11134","Peve_00041130",0.998868511449619,0.0302873419647936,0.903929377050813,162,-24.53,"2 19","497 518",17,"64.71%","94.12%","Q9WV98","Mitochondrial import inner membrane translocase subunit Tim9","Mus musculus (Mouse)","protein insertion into mitochondrial inner membrane [GO:0045039]","GO:0005739; GO:0005743; GO:0005758; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0046872; GO:0051087"
"2321",2500,912630,"Cluster_9149","Peve_00000334",1,0,0,162,-28.39,"2 21","482 502",19,"73.68%","84.21%",NA,NA,NA,NA,NA
"2331",2510,914450,"Cluster_1167","Peve_00008498",0.999909726776791,0.00855416971793915,0.573710369894872,149,-22.35,"2 21","811 830",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"2340",2520,917593,"Cluster_15890","Peve_00029820",-0.998956013089957,0.02909245946257,0.903929377050813,152,-21.12,"2 21","158 178",20,"70.00%","80.00%","Q504H8","Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1)","Danio rerio (Zebrafish) (Brachydanio rerio)","cell differentiation [GO:0030154]; inner ear morphogenesis [GO:0042472]; nervous system development [GO:0007399]; posterior lateral line development [GO:0048916]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007399; GO:0030154; GO:0042472; GO:0048916"
"2346",2526,920173,"Cluster_4735","Peve_00037304",0.99999940598563,0.000693894776259953,0.239778920002343,151,-24.43,"2 18","62 87",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"2348",2528,921158,"Cluster_2882","Peve_00027617",-0.997171486654887,0.0478935089731376,0.945312205299076,162,-20.21,"2 21","400 420",19,"73.68%","84.21%","Q6PHG8","DNA-directed RNA polymerase I subunit RPA43 (DNA-directed RNA polymerase I subunit F) (Twist neighbor protein)","Danio rerio (Zebrafish) (Brachydanio rerio)","DNA-templated transcription initiation [GO:0006352]","GO:0005736; GO:0006352"
"2359",2539,922458,"Cluster_796","Peve_00017540",0.997011731357393,0.0492281083654383,0.950396228648067,156,-25.69,"2 19","770 790",17,"76.47%","82.35%","P51693","Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1) (APLP) (APLP-1) [Cleaved into: C30]","Homo sapiens (Human)","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; mRNA polyadenylation [GO:0006378]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; nervous system development [GO:0007399]; regulation of translation [GO:0006417]","GO:0005604; GO:0005654; GO:0005794; GO:0005886; GO:0006378; GO:0006417; GO:0006897; GO:0006915; GO:0007155; GO:0007399; GO:0007409; GO:0007417; GO:0008201; GO:0009887; GO:0030198; GO:0030900; GO:0031694; GO:0031695; GO:0031696; GO:0042802; GO:0046914; GO:0048471; GO:0071874; GO:0106072"
"2373",2553,933352,"Cluster_2854","Peve_00029618",-0.999816725191885,0.0121885808006402,0.68064733699131,177,-23.34,"2 18","870 891",16,"93.75%","93.75%","Q8K2X2","RNA-binding protein 48","Mus musculus (Mouse)","","GO:0003723; GO:0005654"
"2407",2587,946518,"Cluster_10061","Peve_00019763",0.998126576037554,0.0389745384665604,0.909359886114279,171,-20.53,"2 21","470 492",20,"75.00%","90.00%","B8V7S0","CUB and peptidase domain-containing protein 1","Acropora millepora (Staghorn coral) (Heteropora millepora)","proteolysis [GO:0006508]","GO:0004252; GO:0005576; GO:0006508"
"2424",2605,952220,"Cluster_6914","Peve_00007832",-0.999985569263183,0.00342010859677409,0.509766725418101,165,-25.93,"2 20","603 625",20,"80.00%","85.00%","Q8WVP7","Limb region 1 protein homolog (Differentiation-related gene 14 protein)","Homo sapiens (Human)","embryonic digit morphogenesis [GO:0042733]; signal transduction [GO:0007165]","GO:0004888; GO:0005886; GO:0007165; GO:0042733"
"2485",2668,972171,"Cluster_11134","Peve_00002105",0.999968584764073,0.00504622278903583,0.551398425649056,148,-20.4,"2 19","607 630",19,"68.42%","78.95%","Q9JID6","Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Palmitoyl-CoA ligase) (Phytanate--CoA ligase) (EC 6.2.1.24)","Cavia porcellus (Guinea pig)","long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0047676; GO:0050197; GO:0070251"
"2493",2676,975603,"Cluster_796","Peve_00028990",0.999428282268221,0.0215281467469576,0.825175158091499,165,-26.57,"2 21","452 471",19,"78.95%","84.21%",NA,NA,NA,NA,NA
"2514",2701,984669,"Cluster_7855","Peve_00003561",0.998823748059417,0.0308807526265784,0.903929377050813,165,-20.1,"2 19","121 145",20,"80.00%","80.00%","O62714","Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1)","Sus scrofa (Pig)","cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of calcium ion transport [GO:0051924]","GO:0004930; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0016597; GO:0042803; GO:0051924"
"2530",2719,989743,"Cluster_4735","Peve_00045236",-0.999310671556481,0.023639221558204,0.851916223620059,166,-20.89,"2 21","859 883",22,"77.27%","81.82%","Q7TMK9","Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)","Mus musculus (Mouse)","cellular response to type II interferon [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of mRNA modification [GO:0090367]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of translation [GO:0045727]; RNA splicing [GO:0008380]","GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006397; GO:0008143; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0043025; GO:0045293; GO:0045727; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0090367; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990635; GO:1990904; GO:2000623; GO:2000767"
"2545",2734,995405,"Cluster_1167","Peve_00000213",0.999909726776791,0.00855416971793915,0.573710369894872,143,-21.79,"2 21","370 395",23,"60.87%","65.22%",NA,NA,NA,NA,NA
"2561",2752,1002828,"Cluster_796","Peve_00038927",0.999994129428633,0.00218140105711895,0.379078774249685,164,-21.21,"2 20","939 958",18,"83.33%","83.33%","Q14832","Metabotropic glutamate receptor 3 (mGluR3)","Homo sapiens (Human)","chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0042734; GO:0043197; GO:0045211; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170"
"2574",2765,1008071,"Cluster_8884","Peve_00026145",0.997253647308052,0.047192471195222,0.941791888778827,158,-20.56,"2 20","712 734",20,"65.00%","85.00%",NA,NA,NA,NA,NA
"2583",2775,1012693,"Cluster_4735","Peve_00042916",0.999824590062268,0.011924181187447,0.672885963152335,173,-22.62,"2 18","311 332",16,"87.50%","93.75%","Q9DBL7","Bifunctional coenzyme A synthase (CoA synthase) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)]","Mus musculus (Mouse)","coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310]","GO:0004140; GO:0004595; GO:0005524; GO:0005759; GO:0015937; GO:0016310"
"2594",2786,1019042,"Cluster_6904","Peve_00002033",-0.997924541017077,0.0410229927440064,0.909359886114279,164,-24.82,"2 21","320 341",19,"68.42%","84.21%",NA,NA,NA,NA,NA
"2604",2796,1022434,"Cluster_10934","Peve_00019364",0.998758250045998,0.0317290557481573,0.903929377050813,162,-21.28,"2 20","488 511",20,"75.00%","80.00%",NA,NA,NA,NA,NA
"2627",2821,1030755,"Cluster_9149","Peve_00020364",1,0,0,148,-20.73,"2 14","333 355",13,"76.92%","92.31%","Q0IH72","Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1)","Xenopus laevis (African clawed frog)","","GO:0003676; GO:0004519; GO:0005743; GO:0046872"
"2653",2849,1039055,"Cluster_1167","Peve_00006941",0.999909726776791,0.00855416971793915,0.573710369894872,153,-20.61,"2 21","29 48",19,"63.16%","84.21%",NA,NA,NA,NA,NA
"2662",2858,1042596,"Cluster_11134","Peve_00031444",0.999598010096097,0.0180516640819476,0.782669382293497,147,-25.38,"2 21","93 117",22,"63.64%","68.18%","Q99JY0","Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]","Mus musculus (Mouse)","cellular response to lipopolysaccharide [GO:0071222]; fatty acid beta-oxidation [GO:0006635]; gene expression [GO:0010467]","GO:0003985; GO:0003988; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0010467; GO:0016507; GO:0042645; GO:0044877; GO:0050633; GO:0071222; GO:0106222"
"2682",2882,1051577,"Cluster_6904","Peve_00016785",-0.99999862897499,0.0010541874922422,0.267974802126026,162,-24.85,"2 17","770 790",15,"86.67%","93.33%","A0JM23","Nephrocystin-3","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","cilium assembly [GO:0060271]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]","GO:0005929; GO:0016055; GO:0060271; GO:0090090; GO:2000095"
"2742",2949,1078369,"Cluster_10934","Peve_00012516",0.998758250045999,0.0317290557481559,0.903929377050813,143,-21.64,"2 21","280 304",22,"63.64%","63.64%",NA,NA,NA,NA,NA
"2757",2964,1086982,"Cluster_2854","Peve_00038025",0.999962448044095,0.00551712420276166,0.551398425649056,157,-20.06,"2 21","561 583",21,"76.19%","76.19%",NA,NA,NA,NA,NA
"2763",2970,1089524,"Cluster_8988","Peve_00039177",-0.999730689576333,0.0147751347211111,0.738007302447873,153,-22.68,"2 21","615 637",21,"66.67%","80.95%",NA,NA,NA,NA,NA
"2784",2997,1099135,"Cluster_4080","Peve_00012704",0.997873729717017,0.0415222938742972,0.909359886114279,159,-21.02,"2 21","191 215",22,"68.18%","77.27%","Q9DC58","DNA damage-regulated autophagy modulator protein 1 (Damage-regulated autophagy modulator)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506]","GO:0005737; GO:0005764; GO:0005765; GO:0006914; GO:0006915; GO:0010506"
"2797",3011,1105657,"Cluster_2854","Peve_00034569",0.999603958340296,0.0179176022280377,0.782669382293497,159,-22.75,"2 21","832 856",22,"63.64%","81.82%",NA,NA,NA,NA,NA
"2808",3024,1110057,"Cluster_15726","Peve_00023336",-0.998934950217099,0.0293845218273416,0.903929377050813,160,-21.55,"2 21","685 705",20,"80.00%","80.00%","Q9NYR8","Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2)","Homo sapiens (Human)","estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601]","GO:0004303; GO:0004745; GO:0005829; GO:0005886; GO:0006694; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0050896; GO:0052650"
"2837",3059,1123385,"Cluster_1167","Peve_00028838",0.999909726776791,0.00855416971793915,0.573710369894872,150,-24.63,"2 20","439 461",19,"68.42%","73.68%","Q8CG08","Collagen triple helix repeat-containing protein 1","Rattus norvegicus (Rat)","cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0001649; GO:0005109; GO:0005581; GO:0005615; GO:0005737; GO:0016477; GO:0016528; GO:0017147; GO:0031012; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0090090; GO:0090103; GO:0090177"
"2862",3085,1134005,"Cluster_1167","Peve_00035609",0.999615266464435,0.0176599336484992,0.782669382293497,148,-21.67,"2 14","99 121",13,"84.62%","84.62%",NA,NA,NA,NA,NA
"2874",3098,1139229,"Cluster_4079","Peve_00044680",0.999969908751759,0.00493874168584727,0.551398425649056,155,-20.12,"2 21","269 291",20,"60.00%","85.00%",NA,NA,NA,NA,NA
"2893",3121,1145622,"Cluster_4629","Peve_00023421",0.997938030915672,0.0408894104551393,0.909359886114279,155,-24.89,"2 12","259 280",10,"100.00%","100.00%","P48040","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor)","Ovis aries (Sheep)","","GO:0005886; GO:0008502"
"2905",3136,1149887,"Cluster_589","Peve_00026462",-0.999999797342096,0.00040530027750834,0.219367948732634,156,-21.22,"2 21","265 286",19,"68.42%","73.68%",NA,NA,NA,NA,NA
"2930",3162,1156462,"Cluster_2854","Peve_00006824",0.999627383900334,0.0173795855218949,0.782669382293497,166,-26.08,"2 15","909 930",13,"92.31%","100.00%",NA,NA,NA,NA,NA
"2968",3202,1169690,"Cluster_1167","Peve_00041291",-0.999403063667998,0.0219978751741613,0.831331530166709,155,-26.97,"2 21","510 535",23,"65.22%","73.91%",NA,NA,NA,NA,NA
"2969",3203,1170394,"Cluster_10934","Peve_00021707",0.998758250045998,0.0317290557481587,0.903929377050813,172,-23.08,"2 21","819 840",19,"78.95%","84.21%","Q4I963","Cofilin (Actin-depolymerizing factor 1)","Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) (Wheat head blight fungus) (Fusarium graminearum)","actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]","GO:0003779; GO:0005737; GO:0007049; GO:0015629; GO:0016363; GO:0030042; GO:0051301"
"2979",3214,1174730,"Cluster_1167","Peve_00033304",0.999582222238082,0.018402757417117,0.782669382293497,142,-21.21,"2 11","413 434",9,"88.89%","88.89%","Q62868","Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2)","Rattus norvegicus (Rat)","actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; chromosome condensation [GO:0030261]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell junction assembly [GO:1901888]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of synapse maturation [GO:0090128]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939]; viral RNA genome replication [GO:0039694]","GO:0000281; GO:0001837; GO:0001843; GO:0001934; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007249; GO:0007266; GO:0008625; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016301; GO:0016525; GO:0018105; GO:0018107; GO:0030036; GO:0030261; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031616; GO:0031644; GO:0032723; GO:0035509; GO:0036464; GO:0039694; GO:0042752; GO:0043410; GO:0045019; GO:0045616; GO:0046872; GO:0048511; GO:0048598; GO:0048813; GO:0051246; GO:0051298; GO:0051496; GO:0061157; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090128; GO:0090271; GO:0097746; GO:0098685; GO:0098974; GO:0098978; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776"
"2996",3235,1184340,"Cluster_9149","Peve_00010520",-0.998460036492421,0.03533508044945,0.909359886114279,143,-20.42,"2 12","373 394",10,"80.00%","90.00%",NA,NA,NA,NA,NA
"3000",3239,1186090,"Cluster_8634","Peve_00000224",0.997367783055753,0.0462009887636632,0.936455415403062,170,-21.44,"2 20","157 179",19,"78.95%","89.47%",NA,NA,NA,NA,NA
"3021",3261,1197896,"Cluster_14999","Peve_00021191",-0.999571546587002,0.018636417521774,0.782669382293497,165,-22.61,"2 21","804 826",21,"80.95%","80.95%",NA,NA,NA,NA,NA
"3029",3269,1200560,"Cluster_1167","Peve_00021645",0.999509218369495,0.0199460559964703,0.803582979632007,146,-21.9,"2 18","23 44",17,"76.47%","76.47%",NA,NA,NA,NA,NA
"3037",3277,1206120,"Cluster_9149","Peve_00038441",1,0,0,143,-23.7,"2 12","945 966",10,"80.00%","90.00%",NA,NA,NA,NA,NA
"3058",3300,1213610,"Cluster_1167","Peve_00042442",0.999909726776791,0.00855416971793915,0.573710369894872,149,-21.05,"2 14","426 447",12,"83.33%","83.33%",NA,NA,NA,NA,NA
"3064",3306,1214713,"Cluster_8888","Peve_00037191",-0.999035100566406,0.0279686222680646,0.900066868667072,154,-22.08,"2 20","356 373",18,"77.78%","83.33%",NA,NA,NA,NA,NA
"3117",3364,1238925,"Cluster_9149","Peve_00014601",1,0,0,156,-22.38,"2 21","899 920",19,"63.16%","78.95%",NA,NA,NA,NA,NA
"3161",3411,1254195,"Cluster_16738","Peve_00033630",0.996966316145993,0.0496009660033097,0.951817778779317,163,-23.49,"2 21","382 405",21,"76.19%","76.19%","Q9K9H0","Isocitrate lyase (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase)","Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) (Bacillus halodurans)","glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099]","GO:0004451; GO:0006097; GO:0006099; GO:0046872"
"3170",3421,1256507,"Cluster_6904","Peve_00007302",-0.999602697635797,0.0179460996686937,0.782669382293497,151,-22.2,"2 13","313 335",12,"91.67%","91.67%","B5DF45","TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6)","Rattus norvegicus (Rat)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; JNK cascade [GO:0007254]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007250; GO:0007254; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0019901; GO:0030316; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0046849; GO:0047485; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679"
"3191",3444,1263079,"Cluster_6906","Peve_00043672",-0.996921218382016,0.0499684699057156,0.953525644311219,159,-20.7,"2 17","859 882",17,"82.35%","82.35%","P26618","Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a)","Mus musculus (Mouse)","adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; lung growth [GO:0060437]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]","GO:0001553; GO:0001701; GO:0002244; GO:0004672; GO:0004714; GO:0005018; GO:0005021; GO:0005161; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0005902; GO:0005929; GO:0007169; GO:0007204; GO:0008210; GO:0008284; GO:0008585; GO:0009653; GO:0009887; GO:0009897; GO:0009986; GO:0010544; GO:0010863; GO:0016477; GO:0018108; GO:0019838; GO:0023019; GO:0030054; GO:0030198; GO:0030324; GO:0030325; GO:0030335; GO:0030424; GO:0030539; GO:0032991; GO:0033327; GO:0033674; GO:0034614; GO:0035790; GO:0038085; GO:0038091; GO:0042060; GO:0042475; GO:0042803; GO:0043235; GO:0043548; GO:0043552; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048557; GO:0048701; GO:0048705; GO:0050731; GO:0050872; GO:0050920; GO:0055003; GO:0060021; GO:0060325; GO:0060326; GO:0060437; GO:0061047; GO:0061298; GO:0062063; GO:0070374; GO:0070527; GO:0071230; GO:0072277; GO:2000739"
"3201",3455,1266882,"Cluster_15726","Peve_00034555",0.999999835926399,0.000364682128698326,0.201157207099209,171,-20.04,"2 20","598 619",18,"83.33%","83.33%","P10079","Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","Strongylocentrotus purpuratus (Purple sea urchin)","","GO:0005509; GO:0005615; GO:0009374; GO:0031410; GO:0032579"
"3237",3495,1284302,"Cluster_589","Peve_00045100",-0.998993624634128,0.0285635082887394,0.903929377050813,159,-20.33,"2 21","24 46",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"3248",3506,1288344,"Cluster_13502","Peve_00024638",0.997844556977271,0.0418062711782387,0.909359886114279,163,-20.88,"2 21","204 227",21,"71.43%","80.95%",NA,NA,NA,NA,NA
"3250",3508,1288978,"Cluster_15890","Peve_00027583",-0.999998513833777,0.00109756150847525,0.276171237895402,166,-22.27,"2 21","702 726",22,"77.27%","81.82%",NA,NA,NA,NA,NA
"3257",3515,1290425,"Cluster_1167","Peve_00024588",0.99826145042459,0.037544956087,0.909359886114279,147,-21.7,"2 12","469 490",10,"90.00%","90.00%","O60268","Uncharacterized protein KIAA0513","Homo sapiens (Human)","","GO:0005737"
"3276",3538,1296417,"Cluster_4629","Peve_00000905",0.997835542257382,0.0418936347438744,0.909769090275153,155,-24.56,"2 12","903 924",10,"100.00%","100.00%",NA,NA,NA,NA,NA
"3291",3554,1300710,"Cluster_9149","Peve_00032177",1,9.48637384723993e-09,6.86838308108347e-06,156,-22.28,"2 18","853 876",18,"77.78%","77.78%",NA,NA,NA,NA,NA
"3328",3592,1315245,"Cluster_9149","Peve_00043019",-0.998042064423258,0.0398442086073031,0.909359886114279,162,-24.46,"2 15","294 315",13,"84.62%","100.00%",NA,NA,NA,NA,NA
"3338",3602,1318416,"Cluster_2787","Peve_00015503",0.998952984103862,0.0291346401596183,0.903929377050813,146,-21.22,"2 16","123 146",16,"75.00%","75.00%",NA,NA,NA,NA,NA
"3346",3611,1322012,"Cluster_589","Peve_00009459",-0.996976921072009,0.0495141506171131,0.951254322422111,160,-23.47,"2 19","358 378",17,"76.47%","88.24%",NA,NA,NA,NA,NA
"3361",3627,1326032,"Cluster_6904","Peve_00039844",0.999999795128444,0.000407507833291957,0.220203561024059,155,-23.05,"2 21","24 48",22,"63.64%","77.27%","O04469","Enoyl-CoA delta isomerase 1, peroxisomal (EC 5.3.3.8) (Delta(3),Delta(2)-enoyl CoA isomerase 1) (AtECI1)","Arabidopsis thaliana (Mouse-ear cress)","fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]","GO:0004165; GO:0005777; GO:0006635; GO:0009062"
"3367",3634,1328040,"Cluster_16738","Peve_00010457",0.999924418203837,0.00782720053096207,0.573710369894872,166,-23.26,"2 21","323 343",19,"73.68%","89.47%","Q80T79","CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3)","Mus musculus (Mouse)","negative regulation of complement activation, classical pathway [GO:0045959]; regulation of dendrite development [GO:0050773]","GO:0005615; GO:0005886; GO:0045959; GO:0050773"
"3375",3642,1331712,"Cluster_8887","Peve_00003756",-0.999888656727405,0.00950016485251684,0.60604832750937,154,-21.23,"2 20","549 570",19,"68.42%","78.95%",NA,NA,NA,NA,NA
"3385",3653,1334894,"Cluster_5563","Peve_00000470",0.998070534296603,0.0395533713646997,0.909359886114279,161,-21.83,"2 20","946 970",20,"75.00%","85.00%","A7RR04","Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)","Nematostella vectensis (Starlet sea anemone)","mitochondrial translational elongation [GO:0070125]","GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125"
"3388",3658,1336221,"Cluster_11134","Peve_00000107",0.999846092086893,0.0111694339890098,0.652903054366067,153,-21.65,"2 15","117 139",14,"78.57%","92.86%","Q6PE54","Probable ATP-dependent RNA helicase DHX40 (EC 3.6.4.13) (DEAH box protein 40)","Mus musculus (Mouse)","","GO:0003723; GO:0003724; GO:0005524; GO:0016887"
"3416",3692,1348442,"Cluster_6904","Peve_00002367",-0.998173851896017,0.0384794833063825,0.909359886114279,164,-23.3,"2 21","643 664",19,"73.68%","78.95%",NA,NA,NA,NA,NA
"3426",3702,1350518,"Cluster_7658","Peve_00008040",-0.999314839069881,0.0235676465242015,0.851706337230628,170,-20.56,"2 21","920 943",21,"80.95%","85.71%","P33610","DNA primase large subunit (DNA primase 58 kDa subunit) (p58)","Mus musculus (Mouse)","DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; positive regulation of DNA primase activity [GO:1903934]","GO:0003677; GO:0005658; GO:0006269; GO:0006270; GO:0046872; GO:0051539; GO:0071667; GO:1903934"
"3429",3705,1351443,"Cluster_796","Peve_00003541",0.998317429681288,0.036935386301087,0.909359886114279,163,-24.23,"2 21","376 398",20,"75.00%","80.00%","Q6TEK8","Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4)","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","vitamin K metabolic process [GO:0042373]","GO:0005789; GO:0042373; GO:0047057; GO:0048038"
"3449",3726,1356522,"Cluster_15726","Peve_00001450",0.999108109553157,0.0268895268710568,0.889863763909286,158,-20.61,"2 21","969 993",22,"72.73%","77.27%",NA,NA,NA,NA,NA
"3472",3752,1364127,"Cluster_15726","Peve_00033678",0.999904013014523,0.0088207349235263,0.583683194376181,168,-20.13,"2 18","144 166",17,"88.24%","88.24%","Q61425","Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)","Mus musculus (Mouse)","fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]","GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006635; GO:0009410; GO:0014823; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162"
"3475",3755,1364925,"Cluster_9149","Peve_00041933",1,0,0,143,-21.67,"2 16","888 909",14,"71.43%","71.43%",NA,NA,NA,NA,NA
"3486",3766,1366923,"Cluster_796","Peve_00032232",0.998122772067377,0.0390140994983106,0.909359886114279,155,-21.08,"2 12","941 962",10,"100.00%","100.00%","Q5R5R4","RUN and FYVE domain-containing protein 2","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0005634; GO:0046872"
"3516",3798,1379758,"Cluster_4735","Peve_00026202",0.99999940598563,0.000693894776195108,0.239778920002343,159,-23.8,"2 21","946 968",20,"70.00%","80.00%",NA,NA,NA,NA,NA
"3532",3817,1387317,"Cluster_4629","Peve_00036582",0.998776265532991,0.0314980026586388,0.903929377050813,163,-24.32,"2 16","77 98",14,"85.71%","92.86%","P30975","Tachykinin-like peptides receptor 99D (Tachykinin-like receptor at 99D) (dTKR)","Drosophila melanogaster (Fruit fly)","detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of synaptic transmission [GO:0050805]; neuropeptide signaling pathway [GO:0007218]; olfactory behavior [GO:0042048]; positive regulation of sensory perception of pain [GO:1904058]; tachykinin receptor signaling pathway [GO:0007217]","GO:0004995; GO:0005886; GO:0007186; GO:0007217; GO:0007218; GO:0008188; GO:0016020; GO:0042048; GO:0050805; GO:0050911; GO:1904058"
"3534",3819,1388730,"Cluster_9149","Peve_00031673",0.999232747668771,0.0249397445505303,0.86745289293403,148,-20.42,"2 18","477 499",17,"64.71%","82.35%","P38062","Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M)","Rattus norvegicus (Rat)","N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal involved in protein maturation [GO:0035551]; protein processing [GO:0016485]","GO:0004177; GO:0005737; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0035551; GO:0046872; GO:0070006"
"3593",3883,1412023,"Cluster_4735","Peve_00018929",0.999041921949982,0.0278695685926089,0.899642249848007,163,-20.67,"2 17","84 106",16,"87.50%","87.50%",NA,NA,NA,NA,NA
"3606",3897,1416129,"Cluster_7855","Peve_00044261",-0.999136681236325,0.0264552555081203,0.885091958128636,176,-20.97,"2 21","648 669",19,"84.21%","84.21%",NA,NA,NA,NA,NA
